
Advanced wound healing techniques, including exosomes and polynucleotides, can enhance post-procedure recovery and reduce pigmentation issues.

Advanced wound healing techniques, including exosomes and polynucleotides, can enhance post-procedure recovery and reduce pigmentation issues.

Nanette Silverberg, MD, discusses new treatments for pediatric vitiligo, including JAK inhibitors and surgical advancements.

Proper nutrition and nutraceuticals can help to manage skin conditions such as acne, eczema, and psoriasis.

A patient-centered approach ensures that hair loss treatments align with individual goals and medical history.

His presentation at South Beach Symposium will feature Zirwas’ insights on JAK inhibitors, eczema treatments, and emerging therapies.

Goldberg noted combination treatments that integrate radiofrequency, ultrasound, and muscle stimulation could improve patient outcomes.

Catch up on coverage from the first day of the 2025 South Beach Symposium held in Miami Beach, Florida.

“The most important tip as a physician, when you talk to the patient, sit down. Even if you sit down for 5 minutes, it's worth almost 5 hours,’ Leon Kircik, MD, said in his interview with Dermatology Times at SBS 2025.

Nada Elbuluk, MD, MSc, emphasizes that medical treatments remain first-line for vitiligo, but stable cases may benefit from surgical options.

Ablon covered all aspects of getting involved in clinical research, such as budgeting, recruiting, and analyzing data.

Michael Gold, MD, shares why the South Beach Symposium remains a must-attend legacy event for dermatologists, blending education and innovation.

According to Silverberg, emotional resilience, social support, and purposeful activities help adolescents cope with acne-related stress.

Nanette Silverberg, MD, highlights new dermatology advancements and the significance of conferences like MOPD in shaping the future of treatment.

Dermatology Times staff will be onsite covering SBS 2025 with expert insights, interviews, and breaking news.

In an interview ahead of the main event, Ablon shared her excitement for SBS and listening in on presentations from industry leaders.

At the Horizons in Advanced Practice meeting, Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, presented a case of a woman aged 35 years with widespread eczematous lesions covering over 50% BSA and severe lichenification.

We want to know: Will you be attending the symposium in Miami Beach this week?

Following his presentation at Winter Clinical Miami, Del Rosso spoke to Dermatology Times about the current treatment landscape of psoriasis.

In his presentation at Winter Clinical Miami, Del Rosso covered a variety of topics including refractory pediatric vitiligo.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of February.

In an interview with Dermatology Times, Del Rosso shared the latest in the treatment landscape for patients with Darier disease.

Del Rosso outlined new and off-label therapies for the disease that he shared in his presentation at Winter Clinical Miami.

In an interview with Dermatology Times, Del Rosso gave insight on off-label therapies that could be used to treat granuloma annulare.

James Del Rosso, DO, explored the treatment landscape and the importance of regular eye exams for patients with AD.

As a part of his presentation at Winter Clinical Miami, Del Rosso discussed new and emerging therapies for acne vulgaris.

At the Horizons in Advanced Practice meeting, Douglas DiRuggiero, DMSc, MHS, PA-C, presented a case of a man aged 47 years with a history of moderate psoriasis for 3 years and a recent diagnosis of psoriatic arthritis

James Del Rosso, DO, shared insights on existing and upcoming therapies for seborrheic dermatitis.

At the Horizons in Advanced Practice meeting, Omar Noor, MD, FAAD, presented a case of a man aged 70 years with a 20-year history of psoriasis who was previously treated with adalimumab.

In his presentation at Winter Clinical Miami, Del Rosso covered new and emerging therapies as well as successful off-label uses.

Three posters supporting VP-315's treatment efficacy and outcomes were presented at the Winter Clinical Miami conference.